POST Online Media Lite Edition


NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (9.21.2021, 5:41pam CEST, WHO):   India 26,115    Brazil 9,458    United Kingdom 35,702    Russia 19,179    Turkey 27,688    Iran 17,397    Columbia 1,813    Italy 2,405    Indonesia 3,263    Germany 4,664    Mexico 4,983    South Africa 1,504    Philippines 18,937    Ukraine 5,159    Malaysia 14,345    Netherlands 1,370    Iraq 3,192    Japan 2,405    Bangladesh 1,562    Thailand 10,919    Pakistan 2,167    Romania 6,789    Morocco 2,246    Serbia 6,424    Jordan 1,075    Cuba 8,544    Nepal 1,036    Austria 1,162    Vietnam 8,681    Greece 2,124    Georgia 2,470    Belarus 1,941    Costa Rica 1,627    Bulgaria 2,360    Myanmar 1,687    Palestine 3,909    Croatia 1,037    Ireland 1,150    Libya 1,081    Lithuania 1,157    South Korea 1,729    Mongolia 2,543    Botswana 1,536    El Salvador 2,323    China 83    Singapore 0    New Zealand 15    Australia 1,515   

New Jersey AG Grewal imposes emergency restrictions on certain prescription medications

Christian Fernsby |
Addressing concerns of potential drug shortages caused by the inappropriate prescribing and hoarding of drugs touted by some as possible treatments for COVID-19, Attorney General Gurbir S. Grewal and the Division of Consumer Affairs announced statewide restrictions for prescribing and dispensing those medications.

Article continues below


Demand for hydroxychloroquine and chloroquine, prescription drugs used to treat malaria and certain chronic inflammatory conditions like lupus and rheumatoid arthritis, has increased nationwide following reports that the drugs are being tested as possible treatments for COVID-19.

Reports have raised concerns that the drugs are being hoarded by people who do not have an immediate need. According to reports from pharmacy associations across the nation, it appears the hoarders include doctors and dentists who are writing prescriptions for themselves or family members.

To reduce the risk of a shortage, the Division of Consumer Affairs, under the direction of Attorney General Grewal, today issued an Administrative Order imposing statewide restrictions on prescribing and dispensing of the drugs.

“We are in the midst of a public health emergency, and we are all in it together,” said Attorney General Grewal. “Stockpiling and hoarding drugs, and inappropriate prescribing for friends and family, is unacceptable. The action we are taking today protects the drug supply so that medications are available when necessary for those who need them most.”

“Medical professionals have a duty to make conscientious prescribing and dispensing decisions that ensure every patient is able to obtain their medication. This includes only issuing prescriptions necessary for the treatment of patients, and in reasonable quantities to ensure continuity of care for all who rely on them,” said Paul R. Rodríguez, Acting Director of the Division of Consumer Affairs. “It is imperative that those rules are not violated, especially during a public health emergency. To ensure adequate supplies of medications to all New Jersey patients during the COVID-19 health crisis, we are imposing restrictions on the prescribing and dispensing of certain drugs that may be in short supply.”

The Division’s order, which applies effective immediately and until further notice, mandates that any prescription for a drug in short supply due to its use in possible treatment of COVID-19, such as hydroxychloroquine and chloroquine, must include a diagnosis or diagnostic code and should be supported in the patient’s record. Prescriptions without this information are invalid and may not be filled by pharmacists.

To address concerns about inappropriate prescribing, prescribers are not to prescribe medications in short supply as prophylaxis against COVID-19 for the prescriber’s family or friends or to stockpile the drugs for office use. In addition, all prescriptions written should be for treatment of conditions within the prescriber’s scope of practice. So, for example, podiatrists, dentists and veterinarians should not be writing prescriptions for medications designed to treat COVID-19. Pharmacists should not fill prescriptions if they believe the prescriber is acting outside the scope of their practice.

Hydroxychloroquine or chloroquine may be prescribed and dispensed for treatment of COVID-19 only if supported by a positive test result, which must be documented on the prescription, and limited to a 14-day supply, with no refills permitted.

The order’s limitations do not apply to orders of medications for inpatient hospital use, or for use in federal or state clinical trials.

The order also does not limit prescriptions of hydroxychloroquine and chloroquine for patients being treated with maintenance prescriptions for preexisting conditions, such as lupus or other autoimmune diseases. These patients may continue to obtain refills of hydroxychloroquine and chloroquine, and are not subject to the 14-day limitation.

In addition, pharmacists may exercise judgment when filling or refilling prescriptions for medications that may soon be in short supply due to increased demand of certain drugs or drug delivery systems due to the COVID-19 pandemic. For example, the demand for metered dose inhalers has increased. A pharmacist may prudently dispense only one metered dose inhaler when a prescription was written for three.

What to read next

Medicaid patients continue high prescription opioid use after overdose
Drug shortages is seriously affecting emergency care
Emergency visits in US reach all-time high 145.6 million patients